Jackie Walling
pharma
Harman
Korea
Biography
Dr. Walling has extensive experience in the clinical development of anticancer drugs and drugs for rare diseases. She is the owner of JW Consulting. Formerly the VP Clinical Development at BioMarin she has also held positions of increasing responsibility at Eli Lilly, and Tularik. Prior to this she did laboratory research on the pharmacology of anticancer drugs. Dr. Walling holds BSc and PhD degrees from the University of Southampton, UK and an MBChB from the University of Bristol
Research Interest
Pharma & Healthcare
